Академический Документы
Профессиональный Документы
Культура Документы
HEMATOLOGY
Test Name (Methodology) Result Flag Units Biological Reference
Interval
Final Impression: Hemodilute aspirate showing small population of myeloid blasts and hematogones. No
definitive immunophenotypically aberrant population identified.
Cellularity: Hemodilute.
Megakaryopoiesis:
Cellularity: Not seen.
Morphology: Cannot be commented upon.
Erythropoiesis:
Cellularity: Mildly increased.
Morphology: Normoblastic maturation.
Myelopoiesis:
Cellularity: Cannot be commented upon.
Morphology: Normal.
Generated On 10-Mar-2020 17:41:58 1872 This is an electronically authenticated laboratory report. Page 1 of 5
AmPath upholds rigorous standards for operational and clinical performance based on US hospital benchmarks. Test results have been furnished in adherence with
these standards and under the terms and conditions found on the reverse. For details, please email AmPath at customersupport@ampath.com.
AmPath Central Reference Laboratory:
Door No. 1-100/1/CCH Nallagandla, Serilingampally
Hyderabad – 500019
040 6719 9977
www.ampath.com Certificate No.MC-2751
NABL ACCREDITED
HEMATOLOGY
Test Name (Methodology) Result Flag Units Biological Reference
Interval
On flow cytometric immunophenotyping, a small population (2-4% of viable events) of myeloid blasts are seen
(CD34 positive / CD117 positive / CD13 positive / CD33 positive / HLA-DR). In addition a smaller population of
B progenitors (~1% of viable events) with normal maturation pattern is noted, suggestive of hematogones. B and T-
Lymphocytes constitute ~2.5% and ~10% of all viable events.
Final Impression: Hemodilute aspirate showing small population of myeloid blasts and hematogones. No
definitive immunophenotypically aberrant population identified.
Comment: Kindly correlate with clinical details, treatment history and other laboratory parameters.
Generated On 10-Mar-2020 17:41:58 1872 This is an electronically authenticated laboratory report. Page 2 of 5
AmPath upholds rigorous standards for operational and clinical performance based on US hospital benchmarks. Test results have been furnished in adherence with
these standards and under the terms and conditions found on the reverse. For details, please email AmPath at customersupport@ampath.com.
AmPath Central Reference Laboratory:
Door No. 1-100/1/CCH Nallagandla, Serilingampally
Hyderabad – 500019
040 6719 9977
www.ampath.com Certificate No.MC-2751
NABL ACCREDITED
HEMATOLOGY
Test Name (Methodology) Result Flag Units Biological Reference
Interval
Final Impression: Hypercellular bone marrow shows megaloblastoid erythroid hyperplasia. See notes.
Microscopic examination:
Biopsy consists of cortical bone, normal bony trabeculae and intertrabecular spaces showing hypercellular bone
marrow (cellularity ~90 %).
Megakaryocytes are adequate in numbers and with dyspoiesis in ~20%, in the form of fragmented nuclei.
Moderate erythroid hyperplasia with normal to megaloblastic maturation is noted.
Myelopoiesis is adequate and shows normal maturation pattern.
Lymphocytes and plasma cells are seen in the background.
Few singly scattered blasts are seen.
Final Impression: Hypercellular bone marrow shows megaloblastoid erythroid hyperplasia. See notes.
Comment: Kindly correlate with clinical details, treatment history and other laboratory parameters, including
Vit12 and folate levels.
Notes: Possibilities considered are – 1) Megaloblastic anemia, 2) Myelodysplastic syndrome without excess of
blasts, 3) Partially treated acute leukemia.
Generated On 10-Mar-2020 17:41:58 1872 This is an electronically authenticated laboratory report. Page 3 of 5
AmPath upholds rigorous standards for operational and clinical performance based on US hospital benchmarks. Test results have been furnished in adherence with
these standards and under the terms and conditions found on the reverse. For details, please email AmPath at customersupport@ampath.com.
AmPath Central Reference Laboratory:
Door No. 1-100/1/CCH Nallagandla, Serilingampally
Hyderabad – 500019
040 6719 9977
www.ampath.com Certificate No.MC-2751
NABL ACCREDITED
HEMATOLOGY
Test Name (Methodology) Result Flag Units Biological Reference
Interval
Final Impression: Hemodilute aspirate showing small population of myeloid blasts and hematogones. No
definitive immunophenotypically aberrant population identified.
Cellularity: Hemodilute.
Megakaryopoiesis:
Cellularity: Not seen.
Morphology: Cannot be commented upon.
Erythropoiesis:
Cellularity: Mildly increased.
Morphology: Normoblastic maturation.
Myelopoiesis:
Cellularity: Cannot be commented upon.
Morphology: Normal.
Generated On 10-Mar-2020 17:41:58 1872 This is an electronically authenticated laboratory report. Page 4 of 5
AmPath upholds rigorous standards for operational and clinical performance based on US hospital benchmarks. Test results have been furnished in adherence with
these standards and under the terms and conditions found on the reverse. For details, please email AmPath at customersupport@ampath.com.
AmPath Central Reference Laboratory:
Door No. 1-100/1/CCH Nallagandla, Serilingampally
Hyderabad – 500019
040 6719 9977
www.ampath.com Certificate No.MC-2751
NABL ACCREDITED
HEMATOLOGY
Test Name (Methodology) Result Flag Units Biological Reference
Interval
On flow cytometric immunophenotyping, a small population (2-4% of viable events) of myeloid blasts are seen
(CD34 positive / CD117 positive / CD13 positive / CD33 positive / HLA-DR). In addition a smaller population of
B progenitors (~1% of viable events) with normal maturation pattern is noted, suggestive of hematogones. B and T-
Lymphocytes constitute ~2.5% and ~10% of all viable events.
Final Impression: Hemodilute aspirate showing small population of myeloid blasts and hematogones. No
definitive immunophenotypically aberrant population identified.
Comment: Kindly correlate with clinical details, treatment history and other laboratory parameters.
Authorized by Dr. Prashant Ajit Deshpande MD (TMH), Postdoctoral Fellow (Hematopathology and
Checked by Mr. Srinivas Molecular Hematology)
Kurapati Consultant - Hematopathology and Molecular Pathology
Associate 10-Mar-2020 17:41
-----End of Report-----
Tests marked with (*) are not included in the scope of NABL accreditation
Generated On 10-Mar-2020 17:41:58 1872 This is an electronically authenticated laboratory report. Page 5 of 5
AmPath upholds rigorous standards for operational and clinical performance based on US hospital benchmarks. Test results have been furnished in adherence with
these standards and under the terms and conditions found on the reverse. For details, please email AmPath at customersupport@ampath.com.